Sobi is an international biopharmaceutical company specialized in rare diseases. Our therapeutic focus includes immunology, hematology, and specialty care. We provide access to innovative treatments that transform life for people with rare diseases. We bring something rare to rare diseases – a belief in the strength of focus, the power of agility and the potential of the people we are dedicated to serving.

Our immunology, hematology, and specialty portfolios, with products that meet high unmet medical needs, represent a new focus that builds on our heritage in rare diseases. We continue to explore further external growth opportunities to strengthen our business and late-stage pipeline, so that we can continue giving more people living with rare diseases access to innovative treatments. 

Sobi is currently recruiting for a Director, Epidemiology and Biostatistics, to join our growing Global Real-World Evidence (GRWE) team within RDMA.  

In this strategic and scientific leadership role, the Director, Epidemiology and Biostatistics, will:

• Provide epidemiology and statistical analytical support for RWE studies
• Contribute to the development of evidence generation plans and design of RWE studies for scientific and regulatory purposes
• Advise study teams on research methodologies and statistical analysis approaches/techniques
• Create and execute (or oversee the execution of) analytic plans for RWE studies
• Contribute to the development of evidence generation plans and design of RWE studies (e.g., systematic literature reviews, database studies, and observational studies/disease registries)
• Ensure epidemiology perspective is adequately and appropriately reflected in study documents e.g., study protocols, case report forms (CRFs), and regulatory documents
• Prepare and presents study results for inclusion in conference abstracts, presentations, and scientific publications
• Participate actively on cross-functional teams and leads sub-team meetings as appropriate
• Interact with authors, referees, and in-house reviewers on scientific manuscripts, clinical conference abstracts, presentations, and posters based on observational study data within the supported therapeutic areas
• Represent the GRWE team during interactions with key external stakeholders including Scientific Advisory Boards and regulatory authorities

Travel may be required (5-10%)

• PhD, DSc or DrPH in Epidemiology, biostatistics, or related field with 7+ years professional experience in a pharmaceutical/biotech, healthcare, academic or research setting
• MS or MPH with 10+ years professional experience in a pharmaceutical/biotech, healthcare, academic or research setting
• the 7+ years of experience will be in study design, research methodology, and statistical analysis and bringing a solid experience in conducting statistical analyses with SAS (Advanced programming skills) or similar statistical software packages

The following skills will make you the ideal candidate:

• Evidence of productivity in epidemiology related/RWE studies as demonstrated by successful design, execution, and publication of epidemiology related/RWE studies
• Excellent written and oral communication/presentation skills and attention to detail 
• Ability to work independently and collaboratively with multidisciplinary teams
• Solid work ethic with demonstrated organizational and problem-solving skills
• Comfortable in a fast-paced environment with frequent changes in scope or direction of projects
• Thorough and up-to-date technical knowledge of epidemiology and relevant biostatistics methods
• Experience using SAS or similar statistical software packages

How to apply?

We have an ongoing selection process in this recruitment and ask you to send your application as soon as possible. Click apply and include your resume in English. 

Why Join Us?

Here at Sobi, our mission and culture get us excited to come to work every day, but here are a few more reasons to join our team:

• Emphasis on work/life balance
• Collaborative and team-oriented environment
• Opportunities for professional growth
• Diversity and Inclusion
• Competitive compensation for your work
• Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments

Sobi is a global company with over 1,900 employees in more than 30 countries and are committed to the societies where we operate. We are a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases, providing reliable access to innovative medicines in the areas of haematology, immunology, and specialty care. Sobi’s share is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.

We know our employees are our most valuable asset and our culture conveys that. We offer a competitive benefits package, to support the health and happiness of our staff.

Sobi Culture
At Sobi, we refuse to accept the status quo. This is because we have witnessed first-hand the challenges facing those affected by rare diseases and have used this knowledge to shape our business to find new ways of helping them.

As a specialized biopharmaceutical company, we are dedicated to rare diseases. And we see this focus as a strength. By effectively turning our research into ground-breaking treatments, we help make medicine more accessible and open more possibilities for patients and more opportunities for those caring for them. This has been our approach since day one, but we know we can’t change the world of rare diseases on our own. Accomplishing this requires strong partnerships with patients, partners and stakeholders across the entire value chain. Together, we define how our business can create solutions that serve the needs of those affected by rare diseases while facilitating sustainable growth
All your information will be kept confidential according to EEO guidelines.